血流导向装置治疗远端循环动脉瘤:一项随机对照研究
FIAT试验的亚组分析纳入46例远端循环动脉瘤患者,随机分为血流导向装置组23例与替代标准管理组23例;12个月治疗失败在FD组为6/23(26.1%),ASMO组为11/22(50.0%),风险比0.52(0.23-1.17),P=.13,差异未达统计学显著。
要点
- 远端循环动脉瘤FD组12个月治疗失败6/23(26.1%),ASMO组11/22(50.0%),风险比0.52(0.23-1.17),P=.13。
- 3个月死亡或依赖(mRS>2)仅1例,为分配至ASMO组的患者。
- 该亚组分析非预设且未设盲,作者认为结果趋势鼓舞但检验效能不足,需进一步随机试验。
核心结论
- FIAT试验中经FD治疗的远端循环动脉瘤显示出鼓舞人心的趋势,但该分析检验效能不足,需进一步随机试验。
研究设计与样本
- FIAT为全纳入平行组1:1随机研究,比较FD与4种替代标准管理选项(弹簧圈栓塞±支架、载瘤血管闭塞、夹闭或观察,由临床判断预设);本亚组分析非预设、未设盲,纳入46例远端循环动脉瘤患者(FD组23例,ASMO组23例)。
诊断标准与关键数值
- 主要安全结局为3个月死亡或依赖(mRS>2);复合主要结局为治疗失败,包括初始治疗失败、随访期间动脉瘤破裂或再治疗、死亡或依赖(mRS>2),或12个月独立核心实验室判定的血管造影残留动脉瘤。
临床应用与阅片要点
- 作者认为FD治疗远端循环动脉瘤的趋势鼓舞人心,但本亚组分析检验效能不足,需进一步随机试验。
局限性
- 本亚组分析非预设。
- 研究未设盲。
- 该分析检验效能不足。
- 需进一步随机试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Flow diversion (FD) has expanded beyond initial indications (proximal carotid artery aneurysms) to include distal circulation aneurysms (on the anterior, middle, or posterior cerebral arteries). Our objective was to examine results obtained from aneurysms in these locations in the Flow Diversion in Intracranial Aneurysm Treatment Trial (FIAT), which compared FD with alternative standard management options (ASMO).
MATERIALS AND METHODS: FIAT was an all-inclusive parallel-group 1:1 randomized study comparing FD with 1 of 4 ASMOs (coiling +/- stenting, parent vessel occlusion [PVO], clipping, or observation, prespecified by clinical judgment). The primary safety outcome was death or dependency (mRS >2) at 3 months. The composite primary outcome was "treatment failure," defined as initial failure to treat the aneurysm; aneurysm rupture or retreatment during follow-up; death or dependency (mRS >2); or angiographic residual aneurysm adjudicated by an independent core laboratory at 12 months. This subgroup analysis was not prespecified, and there was no blinding.
RESULTS: Of the 323 patients in FIAT, 46 (14%) with distal circulation aneurysms were randomly allocated: 23 to FD and 23 to ASMO (coiling +/- stenting 16 patients; PVO, 1 patient; clipping, 3 patients; and observation, 3 patients). Death or dependency at 3 months occurred in 1 patient (allocated ASMO). Treatment failures occurred in 6/23 FD-treated patients (26.1%; 95% CI, 12.6%-46.5%) compared with 11/22 patients treated with ASMO (50.0%; 95% CI, 30.7%-69.3%) (risk ratio = 0.52 [0.23-1.17]; P = .13). Serious adverse events were similar.
CONCLUSIONS: Distal circulation aneurysms treated with FDs in FIAT showed an encouraging trend, but this analysis was underpowered. Further randomized trials are needed.
引用
- Boisseau W, Darsaut TE, Fahed R, et al. Flow Diversion for the Treatment of Distal Circulation Aneurysms: A Randomized Comparison. AJNR Am J Neuroradiol. 2025. PMID: 39694616. doi:10.3174/ajnr.A8620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。